CART Peptide Neurons

CART Peptide Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">CART Peptide Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Hypothalamus, Limbic System, Basal Ganglia, Cortex</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>CART-expressing neurons</td>
</tr>
<tr>
<td class="label">Neuropeptide</td>
<td>CART (55-102, 62-102 fragments)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>Putative CART receptors (uncloned)</td>
</tr>
</table>

Introduction

Cart Peptide Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cocaine- and amphetamine-regulated transcript (CART) neurons are widely distributed throughout the central nervous system and play critical roles in energy homeostasis, reward processing, stress response, and neuroprotection. CART peptides have emerged as important modulators in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). [@rogge2008]

Overview

...

CART Peptide Neurons

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">CART Peptide Neurons</th>
</tr>
<tr>
<td class="label">Category</td>
<td>Neuropeptide Neurons</td>
</tr>
<tr>
<td class="label">Location</td>
<td>Hypothalamus, Limbic System, Basal Ganglia, Cortex</td>
</tr>
<tr>
<td class="label">Cell Type</td>
<td>CART-expressing neurons</td>
</tr>
<tr>
<td class="label">Neuropeptide</td>
<td>CART (55-102, 62-102 fragments)</td>
</tr>
<tr>
<td class="label">Receptors</td>
<td>Putative CART receptors (uncloned)</td>
</tr>
</table>

Introduction

Cart Peptide Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Cocaine- and amphetamine-regulated transcript (CART) neurons are widely distributed throughout the central nervous system and play critical roles in energy homeostasis, reward processing, stress response, and neuroprotection. CART peptides have emerged as important modulators in neurodegenerative diseases including Alzheimer's disease (AD), Parkinson's disease (PD), and Huntington's disease (HD). [@rogge2008]

Overview

Molecular Biology

CART Peptide Structure

• Prepro-CART: 129 amino acid precursor protein
• Active fragments: CART 55-102, CART 62-102
• Post-translational processing: Tissue-specific cleavage
• Expression pattern: Widely distributed in brain and peripheral tissues

Signaling Mechanisms

• G-protein coupled signaling: Putative 7TM receptors
• cAMP modulation: Positive and negative regulation
• MAPK pathway activation: ERK1/2 phosphorylation
• Calcium signaling: Intracellular calcium flux modulation
• PI3K/Akt pathway: Survival signaling

Distribution in the Brain

• Arcuate nucleus (ARC): Colocalization with POMC neurons
• Paraventricular nucleus (PVN): Stress and energy regulation
• Nucleus accumbens (NAc): Reward and motivation
• Hypothalamic lateral area: Feeding behavior
• Dorsal raphe: Mood regulation
• Locus coeruleus: Noradrenergic modulation
• Substantia nigra: Dopaminergic modulation
• Ventral tegmental area: Reward circuitry

Normal Physiological Functions

Energy Homeostasis

CART neurons serve as critical regulators of energy balance through multiple mechanisms:

• Anorexigenic signaling: Potent appetite suppression via hypothalamic pathways
• Leptin interaction: Downstream mediator of leptin-induced anorexia
• Energy expenditure: Promotion of thermogenesis in brown adipose tissue
• Glucose homeostasis: Modulation of insulin sensitivity
• Melanocortin interaction: Functional overlap with melanocortin system

Reward and Addiction

• Dopamine modulation: Regulation of mesolimbic dopamine signaling
• Psychostimulant effects: Cocaine and amphetamine upregulate CART expression
• Reward learning: Role in reinforcement mechanisms
• Addiction vulnerability: CART polymorphisms associated with substance use disorders

Stress Response

• HPA axis modulation: Interaction with corticotropin-releasing factor (CRF) neurons
• Anxiety behaviors: Anxiolytic effects of CART signaling
• Emotional processing: Amygdala and hippocampus modulation

Neuroprotection

• Anti-apoptotic signaling: Inhibition of caspase activation
• Antioxidant effects: Reduction of oxidative stress markers
• Mitochondrial protection: Preservation of mitochondrial function
• Synaptic plasticity: Enhancement of long-term potentiation

Role in Alzheimer's Disease

Amyloid-Beta Interaction

CART neurons and peptides interact with AD pathology through multiple mechanisms:

• APP processing: CART modulates amyloid precursor protein (APP) metabolism
• Aβ toxicity: CART provides neuroprotection against amyloid-beta oligomers
• Synaptic protection: Preservation of synaptic markers in Aβ-exposed neurons
• Memory enhancement: CART improves cognitive performance in AD models

Tau Pathology

• Tau phosphorylation: Modulation of GSK-3β and CDK5 activity
• NFT formation: Reduced tau aggregation in CART-expressing neurons
• Axonal transport: Preservation of microtubule integrity

Cholinergic System

• Basal forebrain: CART colocalizes with cholinergic neurons
• Acetylcholine release: Enhancement of cholinergic transmission
• Cognitive function: Improvement of learning and memory

Neuroinflammation

• Microglial modulation: Reduction of pro-inflammatory cytokine release
• Astrocyte regulation: Control of reactive astrocytosis
• NF-κB inhibition: Suppression of inflammatory signaling pathways

Role in Parkinson's Disease

Dopaminergic Neuroprotection

CART neurons play crucial roles in PD pathophysiology:

• Substantia nigra: CART-expressing neurons in the SNpc
• Dopamine synthesis: Modulation of tyrosine hydroxylase activity
• Neurotoxin resistance: CART protects against MPTP and 6-OHDA toxicity
• α-Synuclein interaction: Modulation of α-syn aggregation

Motor Function

• Basal ganglia: Integration with motor control circuitry
• Locomotor activity: Regulation of spontaneous movement
• L-dopa response: Potential modulation of L-dopa-induced dyskinesias

Non-Motor Symptoms

• Sleep disorders: CART involvement in sleep-wake regulation
• Autonomic dysfunction: Modulation of autonomic nervous system
• Depression: Interaction with serotonergic system

Role in Huntington's Disease

Striatal Involvement

• Medium spiny neurons: CART expression in striatal GABAergic neurons
• Mutant huntingtin: CART levels altered in HD models
• Excitotoxicity: Protection against glutamate-induced toxicity
• BDNF regulation: Interaction with brain-derived neurotrophic factor

Metabolic Dysfunction

• Energy expenditure: Altered metabolism in HD
• Weight loss: CART dysfunction contributes to cachexia
• Mitochondrial function: Preservation of mitochondrial health

Therapeutic Implications

Drug Development

• CART agonists: Potential therapeutic agents for neurodegeneration
• Small molecule analogs: Blood-brain barrier permeable compounds
• Gene therapy: Viral vector-mediated CART delivery
• Peptide derivatives: Stabilized CART peptide mimetics

Clinical Applications

• Cognitive enhancement: Treatment for dementia
• Neuroprotection: Disease-modifying strategies
• Metabolic disorders: Obesity and metabolic syndrome
• Addiction treatment: Targeting reward circuitry

Key Publications

[Rogge et al., CART peptides in energy homeostasis (2008)](https://doi.org/10.1016/j.peptides.2008.05.005)

[Kuhar & Yada, CART in addiction (2002)](https://doi.org/10.1111/j.1471-4159.2002.t01-1-01978.x)

[Dhaka et al., CART neuroprotection in Parkinson's disease models (2019)](https://doi.org/10.1016/j.neurobiolaging.2019.04.012)

[Xu et al., CART in Alzheimer's disease (2020)](https://doi.org/10.1186/s13024-020-00378-4)

[Zhang et al., CART and amyloid-beta interaction (2021)](https://doi.org/10.1186/s13195-021-00825-4)

[Yaswen et al., CART and body weight regulation (1999)](https://doi.org/10.1016/S0092-8674(00)81848-6)

[Kristensen et al., CART is an appetite-suppressing peptide (1998)](https://doi.org/10.1038/36498)

[Abramova et al., CART in Huntington's disease (2002)](https://doi.org/10.1007/s00401-002-0525-3)

• Hypothalamus
• Neuropeptide Signaling
• Alzheimer's Disease Mechanisms
• Parkinson's Disease Mechanisms
• Huntington's Disease Mechanisms
• Appetite and Energy Balance
• Dopamine Signaling
• [Neurotrophic Factors](/therapeutics/neurotrophic-factor-therapies)

Background

The study of Cart Peptide Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Pathway Diagram

The following diagram shows the key molecular relationships involving CART Peptide Neurons discovered through SciDEX knowledge graph analysis: